Del 42

Progress in Medicinal Chemistry

Inbunden, Engelska, 2004

Av F.D. King, F.D. (SmithKIine Beecham Pharmaceuticals<br>New Frontiers Science Park (North)<br>Third Avenue) King, F. D. King

2 559 kr

Beställningsvara. Skickas inom 7-10 vardagar
Fri frakt för medlemmar vid köp för minst 249 kr.

This volume includes information on recent advances in five important areas: an account of inhibitors of the caspase family of proteolytic enzymes that represent a new class of anti-inflammatory and antiapoptotic agents of potential value in rheumatoid arthritis; and a survey of semi-synthetic and totally synthetic antibiotics and anti-HIV agents and their sites of interaction; the development of inhibitors of the intracellular enzyme acyl-CoA: cholesterol O-acyltransferase (ACAT) for the treatment of hypercholesterolemia; a description of recent progress in growth hormone secretagogues, with the focus on strategies to improve oral bioavailability and duration of action; and information on inhibition of the proteolytic enzyme, hepatitis C protease N-3(NS3), (required for vital replication) as one of the most attractive targets for HCV infections.

Produktinformation

  • Utgivningsdatum2004-04-15
  • Mått152 x 229 x 0 mm
  • Vikt690 g
  • FormatInbunden
  • SpråkEngelska
  • SerieProgress in Medicinal Chemistry
  • Antal sidor450
  • FörlagElsevier Science
  • ISBN9780444511430

Tillhör följande kategorier